Top 50 Life Science Startup Investors in Asia in January 2026
A list of 50 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Asia. We rank investors based on the number of investments they made in Life science companies from Asia. We update this investor list every month.Top 50 Life Science Startup Investors in Asia in January 2026
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Seed, Funding Round, Series A
- China, United States, United Kingdom
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Series C
- China, United States, Singapore
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
We help founders build enduring companies.
Show more
Investment focus
- Health Care, Biotechnology, Artificial Intelligence
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- Keystone — Kesytone is a hardware wallet for bitcoin, Ethereum, USDT, BCH, and cryptocurrencies.
- Ronghe Medical — Ronghe Medical is a medical device manufacturer specializing in the design, research and development, production, and sales of high-end medical device systems based on advanced energy ablation technology platforms, delivering innovative therapeutic solutions that enhance clinical precision, improve patient outcomes, and support a wide range ofmedical applications.
- InfStones — Founded in 2018 with offices across three countries and two continents, InfStones is the world's leading blockchain infrastructure provider. Currently, InfStones provides services to large institutional clients around the globe, supporting thousands of nodes on more than 50 public blockchains through its universal platform.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more
Investment focus
- Manufacturing, Biotechnology, Health Care
- Funding Round, Seed, Series A
- Japan, Singapore, Austria
Portfolio highlights
- Innovacell — Wir entwickeln innovative zelltherapeutische Arzneimittel zur Behandlung von Stuhl- und Harninkontinenz durch Regeneration.
- Illumi Medical — Illumi Medical is a manufacturing company that produces medical equipment and devices for the healthcare sector.
- Blue Whale Energy — Blue Whale Energy connects and optimises distributed batteries across Singapore, helping businesses and solar developers unlock new revenue streams while supporting a cleaner, more reliable grid.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more
Investment focus
- Medical, Biotechnology, Information Technology
- Series A, Seed, Series B
- Japan, United States, United Kingdom
Portfolio highlights
- Mui Lab — Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- Oishii — Oishii Farm provides indoor vertical farming technology. Oishii sells via supermarkets, offering a container of between eight and 11 strawberries for $50 per package. Hiroki Koga and Brendan Somerville started the company in 2017.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Germany
Portfolio highlights
- ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
- Moyang Biotechnology — Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.
- Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more
Investment focus
- Information Technology, Software, Health Care
- Funding Round, Series A, Series B
- Japan, United States, Singapore
Portfolio highlights
- Superworm — Superworm is a producer of environmentally friendly and long-term solutions to societal challenges. The company undertakes genome editing research and sells protein powders, biofuels, and organic fertilizers made from superworms, allowing customers to consume insect-derived proteins and biofuels.
- Nehan — Nehan is a software firm that offers AI bidding information and a media outlet that delivers to local government businesses.
- Space quarters — Space Quarters is a manufacturing company that produces payload deploy and panels, and develops space assembly robotic systems.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more
Investment focus
- Health Care, Internet, Information Technology
- Funding Round, Seed, Series A
- Japan, United States, Ethiopia
Portfolio highlights
- Welyco — Welyco is an information technology company.We operate smart restaurant "solto". Utilize IT to realize efficient and diverse restaurant management.
- Pale Blue — Water propulsion systems for sustainable space development
- Fabric Tokyo — FABRIC TOKYO is a Japanese startup provides a direct-to-consumer custom-made apparel brand. (former-company name Lifestyle Design Co., Ltd.). It enables customers to save their sizes, idea fabrics, and favorite designs, allowing them to make their original clothing later.FABRIC TOKYO was founded in 2012 by Yuichiro Mori and is based in Tokyo,Japan.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series C, Series B
- China, United States, India
Portfolio highlights
- QureBio — QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug developmentincluding phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform.The company was founded in 2017 and is based in Pudong District, Shanghai.
- Pleryon Therapeutics — Innovations in biofunctional polymers
- Tingsheng Technology — TINGSN develops Intracardiac echocardiography (ICE) catheter imaging technology designed to treat cardiac arrhythmia. In addition to ICE products, the company has developed its own heart internal catheter positioning and software algorithms and is developing China first computer surgical simulator for cardiac electrophysiology based on digitalheart model.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more
Investment focus
- Information Technology, Software, Health Care
- Funding Round, Series A, Series B
- Japan, United States, Singapore
Portfolio highlights
- Morus — Morus is a university-based biotech startup developing functional food ingredients from silkworms to address global health and nutrition challenges.
- Nehan — Nehan is a software firm that offers AI bidding information and a media outlet that delivers to local government businesses.
- Space quarters — Space Quarters is a manufacturing company that produces payload deploy and panels, and develops space assembly robotic systems.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology.
The firm was founded in 2014 and based in Osaka, Japan.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- QunaSys — Quantum physics is a relatively new field built since the beginning of the 20th century, but we have used MRI (nuclear magnetic resonance equipment) and lasers used for close examinations in hospitals, and semiconductors mounted on computers. Supports the technology that supports the daily life of people.QunaSys was established to bring out thequantum physics that has been active behind the scenes to the front stage, and to make use of quantum properties to realize technologies that could not be achieved with existing technologies.
- Thinker — Thinker provides sales of proximity sensors and proposed solutions using these products.
- Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Hong Kong
Portfolio highlights
- AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
- CART Medical — CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory.
- Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more
Investment focus
- Biotechnology, Pharmaceutical, Health Care
- Series A, Series B, Series C
- United States, China, Israel
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Funding Round, Seed
- Japan, United Kingdom
Portfolio highlights
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- Space quarters — Space Quarters is a manufacturing company that produces payload deploy and panels, and develops space assembly robotic systems.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.
Show more
Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Angel, Series A
- China, Germany, Hong Kong
Portfolio highlights
- BTRY — BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies.
- TARS — Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.
- NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.
Show more
Investment focus
- Artificial Intelligence, Software, Information Technology
- Seed, Angel, Pre-Seed
- China, United States, Singapore
Portfolio highlights
- TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
- Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
- Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.
Show more
Investment focus
- Biotechnology, Software, Manufacturing
- Series A, Series B, Funding Round
- United States, Canada, Spain
Portfolio highlights
- 6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
- e-Zinc — Founded in 2012, e-Zinc is a Toronto, Canada, based corporation that has developed a breakthrough electrochemical technology for storing energy in zinc metal. This low-cost, flexible, and long-duration energy storage solution will provide the platform for the world’s energy markets to be fully powered by renewable energy, enabling a zero-carbonenergy future.
- CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.
ULTIMA is an investment management firm.
Show more
Investment focus
- Hardware, Software, Agriculture
- Angel, Series A
- China
Portfolio highlights
- Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more
Investment focus
- Manufacturing, Medical, Health Care
- Series A, Seed, Series B
- China, United States, India
Portfolio highlights
- Micot — Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
- Deruicore — Deruicore is an integrated research and development based manufacturing company.
- Zhisheng Bio — Zhisheng Bio specialzies in product research and development, and market transformation of biopharmaceutical products.
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more
Investment focus
- Manufacturing, Biotechnology, Health Care
- Series A, Series B, Seed
- China, Singapore, Norway
Portfolio highlights
- RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
- HEMO BIOENGINEERING — HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
- Hecheng New Materials Technology — Hecheng New Materials Technology is a manufacturing company offering bearing electrical corrosion and electrical insulation solutions.
Senshu Ikeda Capital offers financial consultancy services.
Show more
Investment focus
- Software, Internet, Information Technology
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- HOLO BIO — HOLO BIO is a research and technology firm that employs biological breeding techniques to address the food challenges faced by humanity.
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more
Investment focus
- Information Technology, Software, Internet
- Funding Round, Series A, Series B
- Japan, United States, China
Portfolio highlights
- Lavol —
- Morus — Morus is a university-based biotech startup developing functional food ingredients from silkworms to address global health and nutrition challenges.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more
Investment focus
- Information Technology, Software, Financial Services
- Series B, Series A, Funding Round
- Japan, South Korea, United States
Portfolio highlights
- Prorata.AI — ProrataAI builds technology that enables generative AIs to properly attribute contributing content and share revenues on a per-use basis.
- Innovacell — Wir entwickeln innovative zelltherapeutische Arzneimittel zur Behandlung von Stuhl- und Harninkontinenz durch Regeneration.
- ASTRO — Situs Belanja Kebutuhan Harian Online dengan Harga Terjangkau dan Kualitas Terbaik. Pesan Kebutuhan Harian di ASTRO Pasti Sampai dalam Hitungan Menit
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series A, Seed
- Japan, United States
Portfolio highlights
- Trustart — Trustart engages in real estate research business and real estate big data provision. The company offers real estate big data and big data subscriptions.
- Upward — UPWARD is highly by linking CRM · schedule map / location information, is a cloud service for the visiting business of field sales easier. Field salespersons who have many customers and who are out of the office feel that it is difficult to grasp all customers to Kampek and measure the timing of visits no matter how memorable they are.
- Tech Doctor — Tech Doctor is a health monitoring service which provides analysis and insights for self care reducing the need for health care workers.
ASBV focuses on early and mid-term venture capital investments.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Angel
- China, Australia, Hong Kong
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
- Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
- Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.
Show more
Investment focus
- Manufacturing, Health Care, E-Commerce
- Series A, Series B, Series C
- China, United States, Japan
Portfolio highlights
- Xiaohongshu — Xiaohongshu is a lifestyle-sharing platform for users to share positive energy and good life through the sharing of text, pictures, and videos. Xiaohongshu offers an overseas shopping tip app. Xiaohongshu started its business by helping overseas travelers to draft a shopping list before they hit the roads. But with the aggregation of more UGCcontent, the service is transforming into a community for those who are passionate about fashion and shopping and want to know more about these fields even though they do not have overseas traveling plans on their schedules.
- Healthy Tree — Healthy Tree is a comprehensive solution provider for self-medication devices.
- Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more
Investment focus
- Information Technology, Software, Artificial Intelligence
- Series A, Funding Round, Series B
- Japan, United States, Israel
Portfolio highlights
- QREATION — QREATION is a digital intellectual property studio specializing in producing a wide range of popular content that originates primarily from social media platforms. The company focuses on creating high-quality short-form entertainment, including short dramas, comedy sketches, and variety shows.
- Forward — Forward is a SaaS-based startup that offers recruitment agency services.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.
Show more
Investment focus
- Manufacturing, Software, Electronics
- Series A, Funding Round, Angel
- China
Portfolio highlights
- Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
- Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
- Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.
Show more
Investment focus
- Manufacturing, Semiconductor, Hardware
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- Huachen Core Light — Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.
- Beijing Ruidaen Technology Co. — Beijing Ruidaen Technology Co. is a manufacturer of target detection, radio interference, and laser electronic series.
- Northern Hemisphere Technology — Northern Hemisphere Technology is a high-tech company specializing in automotive-grade one-piece molded inductors. Northern Hemisphere focuses on high-performance and high-quality products, uses technology to serve customers and the market.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, United States, South Korea
Portfolio highlights
- Obita — Obita is a B2B financial network that offers stablecoin-driven transactions for enterprises, merchants, and fintechs.
- X Square — X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.
- Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Kenya
Portfolio highlights
- AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
- Kunwei Technology — Kunwei Technology manufactures high-precision force sensors (six-axis force sensors) as well as force control systems. It is involved in the research and development, manufacturing, sales, and technological promotion of intelligent force sensors, as well as the development of force sensor products for the robot and other intelligent equipmentindustries. It provides force measurement systems as well as goods connected to measurement and other industries.
- New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
Orient Securities Capital Investment is an private equity fund business platform.
Show more
Investment focus
- Manufacturing, Health Care, Medical
- Series A, Funding Round, Series B
- China
Portfolio highlights
- Picea Motion — Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.
- Xinhui Lianxin — Xinhui Lianxin is an electronic component manufacturer, mainly engaged in the manufacturing of special equipment for semiconductor devices, semiconductor discrete devices, power electronic components, integrated circuit manufacturing, integrated circuit chips and product manufacturing.
- Haifu Technology — Haifu Technology is a high-tech company specializing in automobile manufacturing and robotics.
Starlight Capital provides investment and assistance to companies from the digital industry. It searches for businesses that are focusing on digital transformation and helps with its management. Starlight Capital is based in Shanghai, China.
Show more
Investment focus
- Manufacturing, Robotics, Software
- Series A, Series C, Series B
- China
Portfolio highlights
- Hailan Acoustics — Hailan Acoustics focuses on the research and development, production and sales of marine sensors and equipment.
- Wanxun Technology — Wanxun Technology is a service robot developer dedicated to flexible, dexterous and interactive service robots for industries and families.
- Kedian Intelligent Cloud — Kedian Intelligent Cloud is an innovative enterprise focusing on the field of industrial hemp.
The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more
Investment focus
- Software, E-Commerce, Artificial Intelligence
- Series A, Seed, Series B
- Hong Kong, Taiwan, United States
Portfolio highlights
- Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
- Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
- Rice Robotics Limited — The friendliest robot at your service.
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more
Investment focus
- Software, Manufacturing, Information Technology
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Aiator — Aiator is an artificial intelligence product and technology solutions company focusing on industrial fields and biotechnology. Founded in 2010 by Silicon Valley Artificial Intelligence Scientist in Shenzhen Qianhai DreamWorks, the core members of the team are from the United States, the United Kingdom, Australia and Hong Kong. Currently, there arefour peacock talents and nearly 30 independent intellectual property rights. Weiai Intelligent is committed to carrying out AI empowerment services for enterprises, reducing costs and increasing efficiency.
- Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.
- Gongjin Microelectronics — Gongjin Microelectronics develops and manufactures electronic components and semiconductor solutions for various industries.
Puhua Capital is an equity investment firm that focuses on early and middle project.
Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more
Investment focus
- Health Care, Medical, Manufacturing
- Series A, Series B, Seed
- China, United Kingdom, United States
Portfolio highlights
- Anten — Anten is a high-tech enterprise dedicated to the research, development, and production of innovative dietary supplements and precision nutrition technologies, aiming to promote personalized health and wellness solutions through scientifically backed formulations and cutting-edge biotechnological advancements.
- Kangweijian Bio — Kangweijian Bio is a health food manufacturer and distributor dedicated to delivering safe, high-quality products and services across global markets, specializing in food and cosmetic raw materials, health food ingredients, pharmaceutical excipients, and animal nutrition.
- Rongrui Technology — Rongrui Technology is an industrial enzyme developer, involved in industrial enzyme research and development; technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion.
Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.
Show more
Investment focus
- Biotechnology, Food and Beverage, Food Processing
- Series A, Seed, Series B
- China, Israel, Singapore
Portfolio highlights
- Cataya Bio — Cataya Bio (Shanghai) Co., Ltd. is a product company powered by an advanced engineering biology platform and biomanufacturing. We engineer microbes and develop clean fermentation processes to manufacture products of high purity, at low cost, and in a sustainable way. We strive to help the world to transition away from petroleum and addressimportant global issues in environmental preservation, carbon emission and climate change.
- Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
- Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.
Our team invests in early-stage digital health and consumer startups at CentreGold Capital.
Show more
Investment focus
- Medical Device, Artificial Intelligence, Internet
- Seed, Series A, Angel
- United States, China, Canada
Portfolio highlights
- Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
- Virgo — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
- WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.
Loyal Valley Capital is a thematic, research-driven private equity firm.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series C, Series B, Series A
- China, United States, Hong Kong
Portfolio highlights
- Chabaidao — Chabaidao is a tea drink brand that aims to create surprises through product development and trendy gameplay.
- DP Technology — DP Technology is a global leader in the "AI for Science" research paradigm, where AI learns scientific principles and data, then tackles key challenges in scientific research and industrial R&D.DP's commitment to interdisciplinary research has led to the creation of the DP "Particle Universe", an array of pre-trainedlarge science models designed to bridge foundational research with practical industrial applications. DP's software suite includes the Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and Piloteye® Battery Design Automation Platform. Together, these platforms form a robust foundation for industrial innovation and an open ecosystem for AI in science, fostering advancements in key areas such as drug discovery, energy, material science, and information technology.
- DP Technology — Deep Technology uses a new generation of molecular simulation technology to tackle micro-scale industrial design difficulties. Founded in 2018 and is based in Beijing China.
Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization).
The firm was founded in 2014 and based in Tokyo, Japan.
Show more
Investment focus
- Manufacturing, Biotechnology, Medical
- Funding Round, Series A, Seed
- Japan, Singapore, Austria
Portfolio highlights
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- LeXiang Intelligence — LeXiang Intelligence is a robotics company that specializes in the development of intelligent consumer-grade robots.
- Zhongcheng Technology — Zhongcheng Technology is a centralized lubrication system developer that focuses on the research and development, manufacturing, sales, and technical services of centralized lubrication systems.
- Titanium Robotics Technology — Titanium Robotics Technology specializing in the development and production of advanced robot hardware and solutions. It focuses on customized services, R&D, and production of robot hardware, aiming to create high-performance, industry standard products, develops lightweight, collaborative robots, humanoid robots, and exoskeletons, leading thesupply chain towards lightweight, miniaturization, and ease of use.
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Portugal
Portfolio highlights
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
- Hongpu Technology — Hongpu Technology is a high-tech enterprise that independently develops high-end instruments and provides high-tech solutions.
Ruijiang Investment is a market-oriented, professional and international fund management company focusing on equity investment funds, industrial investment funds and asset management business, with a management scale of more than 2 billion yuan.
Show more
Investment focus
- Medical, Biotechnology, Electronics
- Seed, Series A, Series C
- China
Portfolio highlights
- Tuo Rui Jing — Tuo Rui Jing is a global molecular diagnostic company with technological innovation at its core.
- Ruixun Biotech — Ruixun Biotech is a Healthcare company.
- Qianjue Technology — Qianjue Technology is a company that created the first full-stack application-level robot model and offers cloud-based artificial intelligence solutions to robot manufacturers.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
- Manufacturing, Biotechnology, Software
- Series A, Series B, Series C
- China, United States, Singapore
Portfolio highlights
- CarDekho — Thinking of buying a car? At CarDekho.com, buy new and used cars, search by filter and preferences, compare cars, read latest news and updates, see 360 views & more!
- Pulse — Pulse is a health care service provider that assess coronary physiology and biomechanics through innovative techniques.
- Paper Boat — Paper Boat healthy and tasty nuts and trail mixes delivered at your doorstep. Our ingredients are prepared individually - our nuts are slow-roasted to preserve its original flavour & maintain crunchiness, our berries are tossed in beautiful aromatic spices, and then combined to bring the perfect balance of flavours.
BMC engaged in asset management, investment management and consulting.
Show more
Investment focus
- CAD, Medical, Computer
- Seed, Series B
- China
Portfolio highlights
- Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
- Jingyao Xinhui Semiconductor — Jingyao Xinhui Semiconductor is the indium phosphide optical chip manufacturer company.
- Suzhou Pelotin Biotechnology — Suzhou Pelotin Biotechnology is a research firm specializing in peptides, recombinant proteins, GE antibodies, and protein expression.
Innoangel Fund is an investment firm that invests in early stage companies.
Show more
Investment focus
- Artificial Intelligence, Manufacturing, Robotics
- Angel, Seed, Series A
- China, Canada, Hong Kong
Portfolio highlights
- PureblueAI — PureblueAI is an AI-powered digital workforce platform operator specializing in enterprise marketing scenarios.
- Realm of Illumination — Realm of Illumination is an AI smarter hardware developer that focuses on the research and development of AI smart terminal equipment and sensors to fulfill the application needs of artificial intelligence and the Internet of Things.
- Weizhen New Materials — Weizhen New Materials is a company focused on the research and development of new materials technologies, primarily focusing on the development and application of high-performance modified nylon materials and multifunctional composite materials.
Shangshi Fund is an investment firm.
Show more
Investment focus
- Information Technology, Hardware, Electronics
- Series A, Angel, Series B
- China
Portfolio highlights
- HurRain NanoTech — HurRain NanoTech is a new functional nanomaterials service provider for atmospheric water generation solutions. It developed a platform for material screening and amplification with functional composite moisture-absorbing interfacial thermal materials as the primary R&D direction, created a product line of atmospheric water generator devicesand interfacial thermal materials, and provided customers with standardized products and solutions.
- Wutong Sensing Control — Wutong Sensing Control is a leading company that specializes in the research, development, and innovation of cutting-edge robotic mechanics and tactile sensing technologies. With a strong focus on advancing automation systems, the company aims to enhance the precision, efficiency, and adaptability of robotic applications in various industries,including manufacturing, healthcare, and consumer electronics.
- Silicon Ceramics New Energy — Silicon Ceramics New Energy is a manufactures synthetic quartz sand and silicon carbide, and offers chip thermal management solutions.
Eisai is a pharmaceutical company that researches and delivers medicines for patients.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series C, Funding Round
- Japan, United States, China
Portfolio highlights
- Seed Therapeutics — Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
- Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
- Lifenet Insurance Company — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Art
Clean Energy
Web3
Organic Food
Big Data
Video Games
Publishing
B2B
Food and Beverage
Payments
Real Estate
Finance
Wellness
Education
Financial Services
Retail
Infrastructure
Android
Beauty
Photography
Biotechnology
Travel
Fitness
Recruiting
Digital Media
Hospitality
Mobile Advertising
Platforms
Cannabis
Manufacturing
Automotive
Social
Wine And Spirits
Medical Device
Crowdfunding
CleanTech
Construction
Mobile Apps
Transportation
InsurTech
Enterprise
Sports
Franchise
LGBT
eSports
Mobile
Enterprise Software
Music
Email
Social Media
Social Network
Oil and Gas
Medical
Fashion
Legal
Local
Film
Life Science
Internet
Theatre
SaaS
Non Profit
Renewable Energy
Sporting Goods
Restaurants
Software
Celebrity
Social Impact
Machine Learning
Cryptocurrency
Blockchain
Agriculture (agtech)
Media (entertainment)
Facebook
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Singapore
Spain
China
Ghana
Armenia
Egypt
Saudi Arabia
Belarus
Hungary
Oceania
Finland
France
Croatia
Africa
Gibraltar
LATAM
Barbados
Georgia
Greece
Asia
Czech Republic
Faroe Islands
Costa Rica
Brazil
Hong Kong
Bahrain
Liechtenstein
Belgium
Denmark
Bermuda
Estonia
Panama
Algeria
Ecuador
Bulgaria
Belize
Chile
Ethiopia
Togo
Rwanda
Slovenia
Myanmar
Poland
Uganda
Lithuania
San Marino
Sweden
Serbia
Sierra Leone
Thailand
Malaysia
Tanzania
Uzbekistan
Zambia
Turkey
Peru
Uruguay
Tajikistan
Russian Federation
Portugal
Liberia
El Salvador
Jersey
Lebanon
Puerto Rico
Senegal
Norway
Zimbabwe
Tunisia
Venezuela
Ukraine
Taiwan
Mexico
Dominican Republic
Bahamas
Iraq
Italy
Iceland
Azerbaijan
Nigeria
Namibia
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Luxembourg
Mali
Pakistan
Philippines
Albania
Israel
Romania
Jordan
Grenada
Argentina
Bangladesh
Kuwait
Mauritius
Malta
Morocco
Nicaragua
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cameroon
Cyprus
Oman
Latvia
Austria
Switzerland
Guatemala
Colombia
Seychelles
Marshall Islands
Investors in Asia by industry
Restaurants
Crowdfunding
Venture Capital
Film
Mobile Advertising
B2B
Mobile Apps
Cryptocurrency
Finance
Payments
Video Games
Food and Beverage
Wine And Spirits
Email
Medical Device
Internet
Social Media
Social Network
Digital Media
Manufacturing
Art
Mobile
Android
Local
Google
Legal
Software
Sports
Construction
Enterprise Software
eSports
Fitness
CleanTech
Automotive
Hospitality
Travel
Recruiting
Platforms
FinTech
Enterprise
Biotechnology
Real Estate
Health Care
Biotech
Consumer
Climate
Impact
Energy
Sustainability
Proptech
Marketplace
SaaS
Hardware
Community
Social
Gaming
Social Impact
Retail
Infrastructure
Fashion
Beauty
Web3
Photography
Sporting Goods
Publishing
Medical
Big Data
Renewable Energy
Oil and Gas
Financial Services
Clean Energy
Transportation
Non Profit
EdTech
Wellness
Blockchain
Theatre
Education
Media (entertainment)
Franchise
Life Science
Music
Agriculture (agtech)
Machine Learning
Organic Food
InsurTech
Artificial intelligence